S. K. Alldred, Y. Takwoingi, and B. Guo, First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening, Cochrane Database Syst Rev, vol.3, p.12600, 2017.

G. Ashoor, A. Syngelaki, M. Wagner, C. Birdir, and K. H. Nicolaides, Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18, Am J Obstet Gynecol, vol.206, issue.4, 2012.

G. E. Palomaki, C. Deciu, and E. M. Kloza, DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study, Genet Med, vol.14, issue.3, pp.296-305, 2012.

A. B. Sparks, C. A. Struble, E. T. Wang, K. Song, and A. Oliphant, Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18, Am J Obstet Gynecol, vol.206, issue.4, p.319, 2012.

R. W. Chiu, R. Akolekar, and Y. W. Zheng, Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study, BMJ, vol.342, p.7401, 2011.

M. Ehrich, C. Deciu, and T. Zwiefelhofer, Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting, Am J Obstet Gynecol, vol.204, issue.3, p.205, 2011.

A. Alberti, L. J. Salomon, L. Lorc'h, and M. , Non-invasive prenatal testing for trisomy 21 based on analysis of cellfree fetal DNA circulating in the maternal plasma, Prenat Diagn, vol.35, issue.5, pp.471-476, 2015.

A. R. Gregg, S. J. Gross, and R. G. Best, ACMG statement on noninvasive prenatal screening for fetal aneuploidy, Genet Med, vol.15, issue.5, pp.395-398, 2013.

D. Kahneman and A. Tversky, Prospect theory: an analysis of decision under risk, Econometrica, vol.47, issue.2, pp.263-292, 1979.

M. Allais, Le comportement de l'homme rationnel devant le risque: critique des postulats et axiomes de l'Ecole americaine, Econometrica, vol.21, issue.4, pp.503-546, 1953.

D. Ellsberg, Risk, ambiguity, and the savage axioms, Q J Econ, vol.75, issue.4, pp.643-669, 1961.

P. K. Han, A. E. Williams, and A. Haskins, Individual differences in aversion to ambiguity regarding medical tests and treatments: association with cancer screening cognitions, Cancer Epidemiol Biomarkers Prev, vol.23, issue.12, pp.2916-2923, 2014.

C. R. Fox and A. Tversky, Ambiguity aversion and comparative ignorance, Q J Econ, vol.110, issue.3, pp.585-603, 1995.

V. Malan, L. Bussières, and N. Winer, Effect of cell-free DNA screening vs direct invasive diagnosis on miscarriage rates in women with pregnancies at high risk of trisomy 21: a randomized clinical trial, JAMA, vol.320, issue.6, pp.557-565, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02624442

G. Milligan, An examination of procedures for determining the number of clusters in a data set, Psychometrika, vol.50, pp.159-179, 1985.

J. H. Ward, Hierarchical grouping to optimize an objective function, J Am Stat Assoc, vol.58, pp.236-244, 1963.

M. R. Anderberg, Cluster Analysis for Applications, 1973.

M. Hill, J. A. Johnson, and S. Langlois, Preferences for prenatal tests for Down syndrome: an international comparison of the views of pregnant women and health professionals, Eur J Hum Genet, vol.24, issue.7, pp.968-975, 2016.

C. Lewis, M. Hill, C. Silcock, R. Daley, and L. S. Chitty, Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake, BJOG, vol.121, issue.5, pp.582-594, 2014.

R. V. Van-schendel, J. H. Kleinveld, and W. J. Dondorp, Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening, Eur J Hum Genet, vol.22, issue.12, pp.1345-1350, 2014.

Y. M. Chan, T. Y. Leung, O. K. Chan, Y. K. Cheng, and D. S. Sahota, Patient's choice between a non-invasive prenatal test and invasive prenatal diagnosis based on test accuracy, Fetal Diagn Ther, vol.35, issue.3, pp.193-198, 2014.

C. Lewis, C. Silcock, and L. S. Chitty, Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake, Public Health Genomics, vol.16, issue.5, pp.223-232, 2013.

E. J. Verweij, D. Oepkes, M. De-vries, M. E. Van-den-akker, E. S. Van-den-akker et al., Non-invasive prenatal screening for trisomy 21: what women want and are willing to pay, Patient Educ Couns, vol.93, issue.3, pp.641-645, 2013.

M. Hill, J. Fisher, L. S. Chitty, and S. Morris, Women's and health professionals' preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests, Genet Med, vol.14, issue.11, pp.905-913, 2012.

R. Tischler, L. Hudgins, Y. J. Blumenfeld, H. T. Greely, and K. E. Ormond, Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake, Prenat Diagn, vol.31, issue.13, pp.1292-1299, 2011.

R. V. Van-schendel, G. C. Page-christiaens, and L. Beulen,

N. Dutch and . Consortium, Trial by Dutch laboratories for evaluation of non-invasive prenatal testing: part II-women's perspectives, Prenat Diagn, vol.36, issue.12, pp.1091-1098, 2016.

Y. Cheng, W. C. Leung, and T. Y. Leung, Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study, BJOG, vol.125, issue.4, pp.451-459, 2018.

A. Tversky and D. Kahneman, Judgment under uncertainty: Heuristics and biases, vol.1982, pp.153-160

J. Grinshpun-cohen, T. Miron-shatz, L. Ries-levavi, and E. Pras, Factors that affect the decision to undergo amniocentesis in women with normal Down syndrome screening results: it is all about the age, Health Expect, vol.18, issue.6, pp.2306-2317, 2015.